ArticleFrontiers in immunology2024

TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma.

Junyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.